In this installment, Dr. Nicole Gormley and Dr. Grzegorz Nowakowski discuss a collaboration between ASH and the FDA that led to a successful workshop on regulatory science in hematology, an event they co-chaired and one that will return Oct. 10–11 at ASH headquarters in Washington, D.C. Dr. Gormley, a hematologist with the FDA, is the Division Director for the Division of Hematologic Malignancies 2 and the Acting Associate Director for Oncology Endpoint Development within the Oncology Center of Excellence. Dr. Nowakowski is a hematologist at the Mayo Clinic Rochester where he serves as the Deputy Cancer Center Director for Clinical Research. Dr. Nowakowski also serves as Chair of the ASH Subcommittee on Clinical Trials.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/